Curi Bio

Manufacturer of drugs for multiple therapautic areas

placeSeattle, Washington, United States calendar_todayFounded 2015 groups47 employees language curibio.com

Registered entities

Social engagement

Social engagement: 9.7K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

7 investors on record; lead investors include Dynamk Capital, Dream CIS.

Investor typeCountShare
Venture capital229%
Private equity114%
Other / undisclosed457%

Recent activity

2 Jul 2026
Event
Joint webinar with Thomas Leahy, PhD from Curi Bio and Nicholas Coungeris, PhD from 28bio on CNS disease modeling and screening
1 Jul 2026
Event
Engineering the Future of Drug Discovery: A Deep Dive into 3D Human Muscle Tissues
30 Jun 2026
Event
23rd ESTIV International Congress
Coming soon